Goodwin Procter and Mintz have advised Synnovation Therapeutics on the transaction. Novartis has entered into a definitive agreement to acquire Pikavation Therapeutics, Inc., a wholly-owned subsidiary...
Novartis Acquires Pikavation Therapeutics and PI3K? Inhibitor Portfolio from Synnovation for Up to $3 Billion
Candel Therapeutics Completes $100 Million Public Offering and Secures Royalty Funding Agreement
Goodwin has advised Candel Therapeutics, Inc. Paul Hastings LLP has advised Citigroup, Cantor and Stifel as joint bookrunning managers. Candel Therapeutics, Inc. has completed an underwritten...
LENZ Therapeutics’ Merger with Graphite Bio
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
Evelo Biosciences’ $25.5 Million Private Placement
Goodwin advised Flagship Pioneering on the investment. Evelo Biosciences, Inc. (Nasdaq:EVLO) announced a securities purchase agreement with investors in a private placement to sell 11,025,334 shares of...
TCR² Therapeutics’ Agreement with Adaptimmune Therapeutics
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
Neuberger Berman’s Creation of NB Secondary Opportunities Fund V LP
Goodwin Procter advised Neuberger Berman on the deal. Neuberger Berman announced its fifth global private equity secondary fund, NB Secondary Opportunities Fund V LP (“SOF V”). SOF...
North Island Ventures’ Closing of NIV Fund II
Goodwin Procter advised North Island Ventures on the deal. North Island Ventures announced the closing of its NIV Fund II with $125 million in commitments. With this...
Bregal Sagemount’s Investment in DentalXChange
Goodwin Procter advised Bregal Sagemount on the deal. Bregal Sagemount announced its strategic investment in DentalXChange. Together the firms are eyeing robust strategic growth led by a...
Drawbridge Realty’s $1.7 Billion Recapitalization of Portfolio of Office Properties
Debevoise & Plimpton has advised Global Atlantic Financial Group on the deal, while Simpson Thacher advised KKR on the deal. Goodwin advised Drawbridge Realty. KKR, a...
G Squared Ascend I’s Business Combination Agreement with Transfix
Goodwin Procter advised G Squared Ascend I on the deal. Latham & Watkins represented Transfix. G Squared Ascend I (NYSE: GSQD), a special purpose acquisition company...
EQRx’s Merger with CM Life Sciences III
Goodwin Procter advised EQRx on the deal while White & Case LLP advised CM Life Sciences III Inc. EQRx, Inc. announced its definitive merger agreement with CM...
Circle’s Business Combination with Concord Acquisition Corp
Goodwin Procter and Matheson advised Circle on the deal. Arthur Cox and Greenberg Traurig advised Concord Acquisition Corp. Circle announced its definitive business combination agreement with Concord...